Proposal of novel natural inhibitors of severe acute respiratory syndrome coronavirus 2 main protease: Molecular docking and ab initio fragment molecular orbital calculations
- PMID: 33962341
- PMCID: PMC8084281
- DOI: 10.1016/j.bpc.2021.106608
Proposal of novel natural inhibitors of severe acute respiratory syndrome coronavirus 2 main protease: Molecular docking and ab initio fragment molecular orbital calculations
Abstract
This paper proposes natural drug candidate compounds for the treatment of coronavirus disease 2019 (COVID-19). We investigated the binding properties between the compounds in the Moringa oleifera plant and the main protease (Mpro) of severe acute respiratory syndrome coronavirus 2 using molecular docking and ab initio fragment molecular orbital calculations. Among the 12 compounds, niaziminin was found to bind the strongest to Mpro. We furthermore proposed novel compounds based on niaziminin and investigated their binding properties to Mpro. The results reveal that the introduction of a hydroxyl group into niaziminin enhances its binding affinity to Mpro. These niaziminin derivatives can be promising candidate drugs for the treatment of COVID-19.
Keywords: COVID-19; Fragment molecular orbital; In silico drug design; Main protease; Molecular docking; Molecular simulation; Moringa oleifera; Natural product; SARS-CoV-2.
Copyright © 2021 Elsevier B.V. All rights reserved.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures









Similar articles
-
An Updated Review on SARS-CoV-2 Main Proteinase (MPro): Protein Structure and Small-Molecule Inhibitors.Curr Top Med Chem. 2021;21(6):442-460. doi: 10.2174/1568026620666201207095117. Curr Top Med Chem. 2021. PMID: 33292134 Review.
-
Docking Paradigm in Drug Design.Curr Top Med Chem. 2021;21(6):507-546. doi: 10.2174/1568026620666201207095626. Curr Top Med Chem. 2021. PMID: 33292135 Review.
-
Active Learning and the Potential of Neural Networks Accelerate Molecular Screening for the Design of a New Molecule Effective against SARS-CoV-2.Biomed Res Int. 2021 May 25;2021:6696012. doi: 10.1155/2021/6696012. eCollection 2021. Biomed Res Int. 2021. PMID: 34124259 Free PMC article.
-
In silico Study to Evaluate the Antiviral Activity of Novel Structures against 3C-like Protease of Novel Coronavirus (COVID-19) and SARS-CoV.Med Chem. 2021;17(4):380-395. doi: 10.2174/1573396316999200727125522. Med Chem. 2021. PMID: 32720605
-
Phytoconstituents as potential therapeutic agents against COVID-19: a computational study on inhibition of SARS-CoV-2 main protease.J Biomol Struct Dyn. 2024;42(19):10539-10550. doi: 10.1080/07391102.2023.2257328. Epub 2023 Sep 15. J Biomol Struct Dyn. 2024. PMID: 37713337
Cited by
-
Effect of pH on stability of dimer structure of the main protease of coronavirus-2.Biophys Chem. 2022 Aug;287:106829. doi: 10.1016/j.bpc.2022.106829. Epub 2022 May 19. Biophys Chem. 2022. PMID: 35635893 Free PMC article.
-
Editorial: Emerging and old viral diseases: Antiviral drug discovery from medicinal plants.Front Pharmacol. 2022 Aug 19;13:976592. doi: 10.3389/fphar.2022.976592. eCollection 2022. Front Pharmacol. 2022. PMID: 36059941 Free PMC article. No abstract available.
-
In Silico Design of Natural Inhibitors of ApoE4 from the Plant Moringa oleifera: Molecular Docking and Ab Initio Fragment Molecular Orbital Calculations.Molecules. 2023 Dec 11;28(24):8035. doi: 10.3390/molecules28248035. Molecules. 2023. PMID: 38138525 Free PMC article.
-
Biological properties of Moringa oleifera: A systematic review of the last decade.F1000Res. 2025 Jan 30;13:1390. doi: 10.12688/f1000research.157194.2. eCollection 2024. F1000Res. 2025. PMID: 39895949 Free PMC article.
-
Moringa oleifera and Its Biochemical Compounds: Potential Multi-targeted Therapeutic Agents Against COVID-19 and Associated Cancer Progression.Biochem Genet. 2025 Apr;63(2):936-959. doi: 10.1007/s10528-024-10758-w. Epub 2024 Apr 7. Biochem Genet. 2025. PMID: 38583096 Review.
References
-
- Pal M., Kerorsa G.B., Kandi V.A. Knowledge update on SARS-Coronavirus-2 (SARS-CoV-2)/COVID-19 and its global public health implications. Am. J. Clin. Med. Res. 2020;8:23–27.
-
- Motiwale M., Yadav N.S., Kumar S., et al. Finding potent inhibitors for COVID-19 main protease (Mpro): an in silico approach using SARS-CoV-3CL protease inhibitors for combating CORONA. J. Biomol. Struct. Dyn. 2020;7:1–12. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous